CME Measurement Experience

How Does Our Experience Impact Your Results?

CME outcomes measurement is scientific but our approach is not necessarily formulaic. We assess and evaluate each client individually to create customized, consultative CME measurement packages using multiple methodologies. Experience is a critical attribute that allows us to make deductive decisions based on prior experience and resulting outcomes. Our clients feel at ease knowing that our experience extends beyond simply repeating the same methods found in other template measurement solutions.


Derek T. Dietze, MA, FACME, CCMEP

President of Improve CME, LLC

Mr. Dietze has 20+ years experience as a CME professional and leads Improve CME’s work with many organizations within the CME community, helping them integrate practical outcomes measurement into their CME program, analyzing, reporting and publishing outcomes measurement results, and leveraging results to improve their CME. He speaks often at CME conferences, has authored several articles on outcomes measurement, is a Fellow of the Alliance for CME, and a past surveyor for the ACCME. Mr. Dietze is a Certified CME Professional, an editorial board member of the peer-reviewed educational outcomes measurement journal CE Measure, an assistant editor for the Alliance for CME Almanac, and a reviewer for He is an advocate for the open, transparent sharing of educational needs assessment and outcomes measurement information. He has a BSc in Biology from the University of Alberta in Edmonton, Canada, an MA in Communications from Brigham Young University in Provo, Utah, and lives near Phoenix, Arizona with his wife and children.


Christopher Viereck, PhD, CCMEP

Chief Scientific Officer of Improve CME, LLC

Dr. Viereck is the Chief Scientific Officer of Improve CME, LLC. His unique perspective and expertise is based on leadership and operational positions in clinical research and education with the pharmaceutical industry. Christopher has 10-years education experience at Sanofi Aventis including VP, Medical Education. He has 7-years experience as a clinical research associate, clinical trial study manager and Global Head of Medical Writing at Merck, Sanofi Aventis and Bayer Schering, respectively. Chris holds a PhD (Magna cum Laude) in developmental neurobiology from the University of Basel, Switzerland (supported by a grant from the Novartis Research Foundation), has published several articles based on his research and is a regular reviewer for Contemporary Clinical Trials.